Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 11.0812.0913.9811.9513.05

What is the latest EV/Core EBITDA ratio of AARTI DRUGS ?

The latest EV/Core EBITDA ratio of AARTI DRUGS is 11.08 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.08
Mar202512.09
Mar202413.98
Mar202311.95
Mar202213.05

How is EV/Core EBITDA of AARTI DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.08
-8.35
Mar2025 12.09
-13.52
Mar2024 13.98
16.99
Mar2023 11.95
-8.43
Mar2022 13.05 -

Other Financial Ratios of AARTI DRUGS


Compare EV/Core EBITDA ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,941.9 Cr 0.8% 5.7% -16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

0.8%

5.7%

-16.2%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses